|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Webb-Waring Institute, University of Colorado Health Sciences Center, Denver, CO, USA
2 Webb-Waring Institute, University of Colorado Health Sciences Center, Denver, CO, USA; Amgen, Inc., Thousand Oaks, CA, USA
* To whom correspondence should be addressed. E-mail: joe.mccord{at}uchsc.edu.
External surfaces of cells are normally protected by extracellular superoxide dismutase, SOD3, which binds to polyanions such as heparan sulfate. We constructed a fusion gene encoding a chimeric SOD consisting of the mature human mitochondrial SOD2 plus the carboxyl-terminal 26-amino acid heparin-binding "tail" from SOD3. This "tail" is responsible for the enzyme's affinity for endothelial surfaces. The fusion gene was expressed in Escherichia coli and the fully active enzyme, SOD2/3, was purified. While native SOD2 has no affinity for heparin, SOD2/3 binds to a heparin-agarose column. In a rat model of acute lung injury induced by intratracheal instillation of IL-1, SOD2/3, SOD2 and denatured SOD2/3 showed 92%, 13.8% and 0% reduction of lung leak, respectively. Only SOD2/3 prevented neutrophil accumulation. In the carrageenan-induced foot edema model in the rat, SOD2/3 reduced edema by 62% (p < 0.003) at a dose where native SOD2 produced no significant effect. Thus, SOD2/3 appears to have properties as a therapeutic anti-inflammatory agent that are greatly superior to other available forms of the enzyme.
This article has been cited by other articles:
![]() |
V. V. Shuvaev, M. Christofidou-Solomidou, F. Bhora, K. Laude, H. Cai, S. Dikalov, E. Arguiri, C. C. Solomides, S. M. Albelda, D. G. Harrison, et al. Targeted Detoxification of Selected Reactive Oxygen Species in the Vascular Endothelium J. Pharmacol. Exp. Ther., November 1, 2009; 331(2): 404 - 411. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Muro, M. Mateescu, C. Gajewski, M. Robinson, V. R. Muzykantov, and M. Koval Control of intracellular trafficking of ICAM-1-targeted nanocarriers by endothelial Na+/H+ exchanger proteins Am J Physiol Lung Cell Mol Physiol, May 1, 2006; 290(5): L809 - L817. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Chu, A. Alwahdani, S. Iida, D. D. Lund, F. M. Faraci, and D. D. Heistad Vascular Effects of the Human Extracellular Superoxide Dismutase R213G Variant Circulation, August 16, 2005; 112(7): 1047 - 1053. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Bowler, M. Nicks, K. Tran, G. Tanner, L.-Y. Chang, S. K. Young, and G. S. Worthen Extracellular Superoxide Dismutase Attenuates Lipopolysaccharide-Induced Neutrophilic Inflammation Am. J. Respir. Cell Mol. Biol., October 1, 2004; 31(4): 432 - 439. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Bonder, D. Knight, D. Hernandez-Saavedra, J. M. McCord, and P. Kubes Chimeric SOD2/3 inhibits at the endothelial-neutrophil interface to limit vascular dysfunction in ischemia-reperfusion Am J Physiol Gastrointest Liver Physiol, September 1, 2004; 287(3): G676 - G684. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Gow and H. Ischiropoulos Super-SOD: superoxide dismutase chimera fights off inflammation Am J Physiol Lung Cell Mol Physiol, June 1, 2003; 284(6): L915 - L916. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |